Maximum Dose Concentration in Final Cohort Yields 85% Pathological Response (6 of 7 Patients); Complete Response (100% Tumor Clearance) in 4 of 6 RespondersNo Serious Adverse Events or Dose-Limiting ...
Early-phase oncology trials carry substantial scientific and commercial risk in cancer drug development. Getting them right ...
Participants will each receive a single intravenous infusion of AFTX-201 at doses determined from preclinical studies.
The phase 2b study is an open-label trial that will enroll 40 men with advanced prostate cancer who are appropriate candidates for ADT. Participants will receive an initial loading dose of teverelix ...
Selene Finance LP has launched the first phase of Selene Cares+, a borrower assistance campaign aimed at streamlining ...
Roche has shared the numbers behind its phase 3 win in primary progressive multiple sclerosis (PPMS), linking its BTK ...
The CEO of DRH Health focused on physician recruitment, programs, new additions and growth during an annual State of Healthcare address at t Chamber of Commerce’s monthly breakfast Thursday ...
Israel's military said Monday it had killed four armed militants who attacked its troops as they emerged from a tunnel in ...
AUBURN, Ala. (WRBL) — The City of Auburn is enacting a Phase I drought watch due to the latest U.S. Drought Monitor Maps indicating that all of Lee County is in severe or extreme drought conditions. A ...
Once overlooked, Morocco has emerged as a focal point of human prehistory, with new discoveries and a landmark report ...
Belfast Live on MSN
Local opposition grows against Botanic GAA pitch plan that will uproot community gardens
Locals are asking for consultation, amidst accusations of decisions being made in secret ...
A new study finds half of all patients did not take enough blood pressure readings, with one third taking none at all.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results